title: Determining the phagocytic activity of clinical antibody samples.
abstract: Antibody-driven phagocytosis is induced via the engagement of Fc receptors on professional phagocytes, and can contribute to both clearance as well as pathology of disease. While the properties of the variable domains of antibodies have long been considered critical to in vivo function, the ability of antibodies to recruit innate immune cells via their Fc domains has become increasingly appreciated as a major factor in their efficacy, both in the setting of recombinant monoclonal antibody therapy, as well as in the course of natural infection or vaccination(1-3). Importantly, despite its nomenclature as a constant domain, the antibody Fc domain does not have constant function, and is strongly modulated by IgG subclass (IgG1-4) and glycosylation at Asparagine 297(4-6).  Thus, this method to study functional differences of antigen-specific antibodies in clinical samples will facilitate correlation of the phagocytic potential of antibodies to disease state, susceptibility to infection, progression, or clinical outcome. Furthermore, this effector function is particularly important in light of the documented ability of antibodies to enhance infection by providing pathogens access into host cells via Fc receptor-driven phagocytosis(7).  Additionally, there is some evidence that phagocytic uptake of immune complexes can impact the Th1/Th2 polarization of the immune response(8). Here, we describe an assay designed to detect differences in antibody-induced phagocytosis, which may be caused by differential IgG subclass, glycan structure at Asn297, as well as the ability to form immune complexes of antigen-specific antibodies in a high-throughput fashion.  To this end, 1 μm fluorescent beads are coated with antigen, then incubated with clinical antibody samples, generating fluorescent antigen specific immune complexes.  These antibody-opsonized beads are then incubated with a monocytic cell line expressing multiple FcγRs, including both inhibitory and activating. Assay output can include phagocytic activity, cytokine secretion, and patterns of FcγRs usage, and are determined in a standardized manner, making this a highly useful system for parsing differences in this antibody-dependent effector function in both infection and vaccine-mediated protection(9).
authors.affiliation: Massachusetts General Hospital, Ragon Institute of MGH, MIT, and Harvard, USA.
authors.forename: Elizabeth G
authors.initials: EG
authors.lastname: McAndrew
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Dugast
authors.forename: Anna F
authors.initials: AF
authors.lastname: Licht
authors.forename: Justin R
authors.initials: JR
authors.lastname: Eusebio
authors.forename: Galit
authors.initials: G
authors.lastname: Alter
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Ackerman
mesh_terms: D000906:Antibodies / Q000276:immunology*; D000936:Antigen-Antibody Complex / Q000276:immunology; D000941:Antigens / Q000276:immunology; D002460:Cell Line; D002478:Cells, Cultured; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D009000:Monocytes / Q000276:immunology; D010586:Phagocytes / Q000276:immunology*; D010587:Phagocytosis / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology
chemical_list: D000906:Antibodies; D000936:Antigen-Antibody Complex; D000941:Antigens; D017452:Receptors, IgG